These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17121380)

  • 1. Therapeutic value of serum uric acid levels increasing in the treatment of multiple sclerosis.
    Toncev G
    Vojnosanit Pregl; 2006 Oct; 63(10):879-82. PubMed ID: 17121380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial.
    Gonsette RE; Sindic C; D'hooghe MB; De Deyn PP; Medaer R; Michotte A; Seeldrayers P; Guillaume D;
    Mult Scler; 2010 Apr; 16(4):455-62. PubMed ID: 20200198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of multiple sclerosis with inosine.
    Markowitz CE; Spitsin S; Zimmerman V; Jacobs D; Udupa JK; Hooper DC; Koprowski H
    J Altern Complement Med; 2009 Jun; 15(6):619-25. PubMed ID: 19425822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease.
    Spitsin S; Hooper DC; Leist T; Streletz LJ; Mikheeva T; Koprowskil H
    Mult Scler; 2001 Oct; 7(5):313-9. PubMed ID: 11724447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction.
    Toncev G; Milicic B; Toncev S; Samardzic G
    Eur J Neurol; 2002 May; 9(3):221-6. PubMed ID: 11985629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
    Ashtari F; Bahar M; Aghaei M; Zahed A
    J Clin Neurosci; 2013 May; 20(5):676-8. PubMed ID: 23528410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis.
    Constantinescu CS; Freitag P; Kappos L
    Mult Scler; 2000 Dec; 6(6):378-81. PubMed ID: 11212132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
    Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
    Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associated Inosine to interferon: results of a clinical trial in multiple sclerosis.
    Muñoz García D; Midaglia L; Martinez Vilela J; Marín Sánchez M; López González FJ; Arias Gómez M; Dapena Bolaño D; Iglesias Castañón A; Alonso Alonso M; Romero López J
    Acta Neurol Scand; 2015 Jun; 131(6):405-10. PubMed ID: 25313094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
    Moccia M; Lanzillo R; Costabile T; Russo C; Carotenuto A; Sasso G; Postiglione E; De Luca Picione C; Vastola M; Maniscalco GT; Palladino R; Brescia Morra V
    J Neurol; 2015; 262(4):961-7. PubMed ID: 25673130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of serum uric acid levels by inosine in patients with multiple sclerosis does not affect blood pressure.
    Spitsin S; Markowitz CE; Zimmerman V; Koprowski H; Hooper DC
    J Hum Hypertens; 2010 May; 24(5):359-62. PubMed ID: 19865105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatment.
    Guerrero AL; Martín-Polo J; Laherrán E; Gutiérrez F; Iglesias F; Tejero MA; Rodríguez-Gallego M; Alcázar C
    Eur J Neurol; 2008 Apr; 15(4):394-7. PubMed ID: 18312403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid levels in patients with multiple sclerosis: a meta-analysis.
    Liu B; Shen Y; Xiao K; Tang Y; Cen L; Wei J
    Neurol Res; 2012 Mar; 34(2):163-71. PubMed ID: 22333889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid: a potential biomarker of multiple sclerosis and of its disability.
    Moccia M; Lanzillo R; Palladino R; Russo C; Carotenuto A; Massarelli M; Vacca G; Vacchiano V; Nardone A; Triassi M; Morra VB
    Clin Chem Lab Med; 2015 Apr; 53(5):753-9. PubMed ID: 25241733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of glatiramer acetate (Copaxone) and interferon beta-1b (Betaferon) in multiple sclerosis patients: an open-label 2-year follow-up.
    Flechter S; Vardi J; Pollak L; Rabey JM
    J Neurol Sci; 2002 May; 197(1-2):51-5. PubMed ID: 11997066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum uric acid and multiple sclerosis.
    Rentzos M; Nikolaou C; Anagnostouli M; Rombos A; Tsakanikas K; Economou M; Dimitrakopoulos A; Karouli M; Vassilopoulos D
    Clin Neurol Neurosurg; 2006 Sep; 108(6):527-31. PubMed ID: 16202511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Serum Zinc Levels in Patients with Multiple Sclerosis Compared to Healthy Controls.
    Pawlitzki M; Uebelhör J; Sweeney-Reed CM; Stephanik H; Hoffmann J; Lux A; Reinhold D
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30049983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta].
    Pokryszko-Dragan A; Bilińska M; Gruszka E; Dubik-Jezierzańska M
    Pol Merkur Lekarski; 2005 Nov; 19(113):654-8. PubMed ID: 16498805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
    Lanzillo R; Di Somma C; Quarantelli M; Ventrella G; Gasperi M; Prinster A; Vacca G; Pivonello C; Orefice G; Colao A; Morra VB
    Eur J Neurol; 2011 Dec; 18(12):1402-6. PubMed ID: 21585623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.